Skip to main navigation Skip to search Skip to main content

Protocol number: GA29145 An Open-Label Extension And Safety Monitoring Study Of Patients With Moderately To Severely Active Crohn’s Disease Previously Enrolled In The Etrolizumab Phase III

Project: Research › OTHER

Project Details

StatusFinished
Effective start/end date1/01/19 → 2/01/23